MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD)
- PMID: 26441222
- DOI: 10.1007/s11064-015-1734-7
MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD)
Abstract
Alzheimer's disease (AD) is an expanding health and socioeconomic concern in industrialized societies, and the leading cause of intellectual impairment in our aging population. The cause of AD remains unknown, and there are currently no effective treatments to stop or reverse the progression of this uniquely human and age-related neurological disorder. Elucidation of the AD mechanism and factors that contribute to the initiation, progression, and spreading of this chronic and fatal neurodegeneration will ultimately result in improved and effective diagnostics and therapeutic strategies.microRNAs (miRNAs) comprise a relatively recently discovered category of 20-24 nucleotide non-coding RNAs that function post-transcriptionally in shaping the transcriptome of the cell, and in doing so, contribute to the molecular-genetics and phenotype of human CNS health and disease. To date about 2550 unique mature human miRNAs have been characterized, however only highly selected miRNA populations appear to be enriched in different anatomical compartments within the CNS.This general commentary for the 'Special Issue: 40th Year of Neurochemical Research' will bring into perspective (i) some very recent findings on the extraordinary biophysics and signaling properties of CNS miRNA in AD and aging human brain; (ii) how specific intrinsic biophysical attributes of miRNAs may play defining roles in the establishment, proliferation and spreading of the AD phenotype; and (iii) how miRNAs can serve as prospective therapeutic targets and biomarkers potentially useful in the clinical management of this terminal neurological disease whose incidence in our rapidly aging population is reaching epidemic proportions.
Keywords: AD diagnostics; Alzheimer’s disease (AD); RNA complexity; Viroids; microRNA (miRNA); non-coding RNA (ncRNA).
Similar articles
-
MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological Features.Int J Mol Sci. 2015 Dec 17;16(12):30105-16. doi: 10.3390/ijms161226223. Int J Mol Sci. 2015. PMID: 26694372 Free PMC article.
-
Addressing Alzheimer's Disease (AD) Neuropathology Using Anti-microRNA (AM) Strategies.Mol Neurobiol. 2019 Dec;56(12):8101-8108. doi: 10.1007/s12035-019-1632-0. Epub 2019 Jun 10. Mol Neurobiol. 2019. PMID: 31183807 Free PMC article. Review.
-
Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.Mol Neurobiol. 2014 Aug;50(1):97-106. doi: 10.1007/s12035-013-8595-3. Epub 2013 Nov 29. Mol Neurobiol. 2014. PMID: 24293102 Free PMC article. Review.
-
Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.Front Neurosci. 2016 Feb 25;10:59. doi: 10.3389/fnins.2016.00059. eCollection 2016. Front Neurosci. 2016. PMID: 26941600 Free PMC article.
-
Studying micro RNA Function and Dysfunction in Alzheimer's Disease.Front Genet. 2013 Feb 6;3:327. doi: 10.3389/fgene.2012.00327. eCollection 2012. Front Genet. 2013. PMID: 23390425 Free PMC article.
Cited by
-
Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders.Front Neurol. 2017 Dec 11;8:670. doi: 10.3389/fneur.2017.00670. eCollection 2017. Front Neurol. 2017. PMID: 29321759 Free PMC article.
-
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints.Transl Psychiatry. 2021 Jan 27;11(1):78. doi: 10.1038/s41398-020-01184-8. Transl Psychiatry. 2021. PMID: 33504764 Free PMC article.
-
A microRNA signature that correlates with cognition and is a target against cognitive decline.EMBO Mol Med. 2021 Nov 8;13(11):e13659. doi: 10.15252/emmm.202013659. Epub 2021 Oct 11. EMBO Mol Med. 2021. PMID: 34633146 Free PMC article.
-
Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.Cell Mol Neurobiol. 2018 Apr;38(3):769-774. doi: 10.1007/s10571-017-0514-0. Epub 2017 Jul 7. Cell Mol Neurobiol. 2018. PMID: 28687876 Free PMC article.
-
Alterations in micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1.J Alzheimers Dis Parkinsonism. 2017 Apr;7(2):312. doi: 10.4172/2161-0460.1000312. Epub 2017 Mar 10. J Alzheimers Dis Parkinsonism. 2017. PMID: 29051843 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical